Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-21

Clinical Trial Update: A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for men with metastatic prostatic adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rampart Health, L.L.C. | Conditions: Metastatic Prostatic Adenocarcinoma | Phase 2 | Status: COMPLETED